Cargando…

Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries

OBJECTIVE: To assess the association between Genomic Classifier (GC)‐risk group and post‐radical prostatectomy treatment in clinical practice. METHODS: Two prospective observational cohorts of men with prostate cancer (PCa) who underwent RP in two referral centers and had GC testing post‐prostatecto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahait, Mohammed, Liu, Vinnie Y. T., Vapiwala, Neha, Lal, Priti, Kim, Jessica, Trabulsi, Eduard J., Huang, Huei‐Chung, Davicioni, Elai, Thompson, Darby J. S., Spratt, Daniel, Den, Robert B., Lee, David I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988525/ https://www.ncbi.nlm.nih.gov/pubmed/35475294 http://dx.doi.org/10.1002/bco2.70

Ejemplares similares

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
por: Marascio, Joseph, et al.
Publicado: (2019)

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IMPACT study
por: Gore, John L., et al.
Publicado: (2017)

Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013)

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery
por: Badani, Ketan K, et al.
Publicado: (2015)

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance
por: Herlemann, Annika, et al.
Publicado: (2019)

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer
por: Patel, Neal, et al.
Publicado: (2022)

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance
por: Kim, Hyung L., et al.
Publicado: (2018)

Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012)

Deciphering the Biological Effects of Radiotherapy in Cancer Cells
por: Lu, Zhou, et al.
Publicado: (2022)

Use of the Decipher genomic classifier among men with prostate cancer in the United States
por: Zaorsky, Nicholas G, et al.
Publicado: (2023)

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
por: Sjöström, Martin, et al.
Publicado: (2019)

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients
por: Den, R B, et al.
Publicado: (2016)

Deciphering Signatures of Mutational Processes Operative in Human Cancer
por: Alexandrov, Ludmil B., et al.
Publicado: (2013)

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
por: Ross, A E, et al.
Publicado: (2016)

Inferring cancer subnetwork markers using density-constrained biclustering
por: Dao, Phuong, et al.
Publicado: (2010)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy
por: Den, Robert B., et al.
Publicado: (2014)

Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race
por: Kensler, Kevin H., et al.
Publicado: (2022)

Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases
por: Ding, Yuan C., et al.
Publicado: (2021)

Racial and ethnic disparities in a real-world precision oncology data registry
por: Cheung, Alexander T. M., et al.
Publicado: (2023)

Deciphering ryanodine receptor array operation in cardiac myocytes
por: Xie, Wenjun, et al.
Publicado: (2010)

Feasibility of Smartphone Application in Plastic Surgery Operative Assessments
por: Almufarrej, Faisal, et al.
Publicado: (2022)

Development of a predictive model for stromal content in prostate cancer samples to improve signature performance
por: Boufaied, Nadia, et al.
Publicado: (2019)

Prostate Cancer Tumor Volume and Genomic Risk
por: Ramaswamy, Ashwin, et al.
Publicado: (2023)

Increasing Diversity in Radiation Oncology: A Call to Action
por: Nead, Kevin T., et al.
Publicado: (2018)

No Talent Left Behind: A Silver Lining for Diversity in Radiation Oncology in the Post–Coronavirus Disease 2019 (COVID-19) Era
por: Kamran, Sophia C., et al.
Publicado: (2020)

Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States
por: Alexidis, P., et al.
Publicado: (2018)

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012)

Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancer
por: Feng, Ye, et al.
Publicado: (2019)

Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer
por: Ganguly, Shinjini, et al.
Publicado: (2023)

Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence
por: Ku, Anson T., et al.
Publicado: (2023)

Association between hospital competition and quality of prostate cancer care
por: Jayadevappa, Ravishankar, et al.
Publicado: (2023)

Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial
por: Feng, Felix Y., et al.
Publicado: (2021)

Decipher
por: Pavlou, S
Publicado: (2001)

Decipher
Publicado: (2002)

A comparative study of PCS and PAM50 prostate cancer classification schemes
por: Yoon, Junhee, et al.
Publicado: (2021)

Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning
por: Baydoun, Atallah, et al.
Publicado: (2018)

Deciphering the Great Mimicker
por: Shih, Jerry J.
Publicado: (2021)

Operative technique for a successful laparoscopic en-bloc resection of gastrogastric fistula following roux-en-Y gastric bypass
por: Patel, Krishna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uduj950ahrh7pojetp6ps5iuhg